Search - tctmd.com

Displaying 541 - 560 of 1188

Sort: Relevancy | Date

News Daily News

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

L.A. McKeown

September 11, 2014

News Daily News

Las PCI Solo del Vaso Causante Podrían ser Mejores en Pacientes IM con Enfermedad Multivaso y Shock Cardiogénico

September 11, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Daily News

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

September 11, 2014

News Daily News

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

September 11, 2014

News Conference News ESC 2014

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Todd Neale

September 08, 2014

Presentation ESC 2014

Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement

Presenter: Biner S. Finkelstein

September 03, 2014

News Conference News ESC 2014

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

Caitlin E. Cox

September 03, 2014

News Conference News ESC 2014

PROTECT: ZES Sustain Lead Over SES at 5 Years

Caitlin E. Cox

September 03, 2014

News Conference News ESC 2014

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

Yael L. Maxwell

September 03, 2014

News Conference News ESC 2014

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

Yael L. Maxwell

September 03, 2014

Presentation ESC 2014

Predictors of Bleeding in ACS Patients Treated With Prasugrel: Analysis From the ACCOAST Study

Presenter: Petr Widimsky

September 02, 2014

Presentation ESC 2014

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

Presenter: Eric Van Belle

September 02, 2014

Presentation ESC 2014

10-year mortality outcome of a routine invasive strategy in non-ST segment elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial

Presenter: Robert A. Henderson

September 02, 2014

News Industry News

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

September 02, 2014

News Industry News

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

September 02, 2014

News Daily News

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

L.A. McKeown

September 02, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Daily News

PROTECT： 4年时采用Endeavor情况下的支架内血栓形成风险更低

L.A. McKeown

September 02, 2014

News Conference News ESC 2014

MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk

Yael L. Maxwell

September 02, 2014

Advertisement

Las Sociedades Europeas Publican Directrices Actualizadas sobre Revascularización en el Manejo de EAC

Las PCI Solo del Vaso Causante Podrían ser Mejores en Pacientes IM con Enfermedad Multivaso y Shock Cardiogénico

European Societies Release Updated Revascularization Guidelines for CAD

Culprit-Vessel-Only PCI May Be Better for MI Patients with Multivessel Disease, Cardiogenic Shock

La Revascularización Incompleta se asocia a Peores Resultados en Pacientes TAVR con EAC

ESC Congress 2014: Positive, Negative Findings Come on Background of Improving Outcomes Overall

Two- year clinical outcome of post procedural mitral regurgitation after transcatheter aortic valve replacement

RITA-3: Advantage of Routine Invasive Strategy for NSTE-ACS Gone by 10 Years

PROTECT: ZES Sustain Lead Over SES at 5 Years

Mitral Regurgitation Associated with Decreased Survival in TAVR Patients

ACCOAST Substudy: Prasugrel Pretreatment Linked With Increased Bleeding in NSTEMI Patients

Predictors of Bleeding in ACS Patients Treated With Prasugrel: Analysis From the ACCOAST Study

Is TAVR the treatment of choice for high risk diabetic patients with aortic stenosis? Insights from the FRANCE2 Registry

10-year mortality outcome of a routine invasive strategy in non-ST segment elevation acute coronary syndrome: the British Heart Foundation RITA 3 randomised trial

Two Year Data from FAME 2 Trial Shows Sustained Benefits of FFR-Guided PCI over Medical Treatment in Patients with Stable CAD

Subgroup Analysis of ENGAGE AF-TIMI 48 Explores the Relationship Between Edoxaban Dose, Concentration, Anti-Factor Xa Activity and Outcomes

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

PROTECT： 4年时采用Endeavor情况下的支架内血栓形成风险更低

MITOCARE: Novel Drug as Adjunct to PCI for STEMI Does Not Reduce Reperfusion Injury Risk

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content